Shopping Cart 0
Cart Subtotal
USD 0

Radiofrequency Catheters - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Radiofrequency Catheters-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Radiofrequency Catheters-Medical Devices Pipeline Assessment, 2018 provides an overview of Radiofrequency Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Radiofrequency Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Radiofrequency Catheters under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Radiofrequency Catheters and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Radiofrequency Catheters under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Radiofrequency Catheters Overview 6

3 Products under Development 7

3.1 Radiofrequency Catheters-Pipeline Products by Stage of Development 7

3.2 Radiofrequency Catheters-Pipeline Products by Territory 8

3.3 Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

3.4 Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

3.5 Radiofrequency Catheters-Ongoing Clinical Trials 11

4 Radiofrequency Catheters-Pipeline Products under Development by Companies 12

4.1 Radiofrequency Catheters Companies-Pipeline Products by Stage of Development 12

4.2 Radiofrequency Catheters-Pipeline Products by Stage of Development 13

5 Radiofrequency Catheters Companies and Product Overview 14

5.1 Handok Inc Company Overview 14

5.1.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Handok-Kalos Medical Company Overview 16

5.2.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 17

5.3.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Medtronic plc Company Overview 18

5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 MicroPort Scientific Corp Company Overview 26

5.5.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Renal Dynamics, LLC Company Overview 27

5.6.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 St. Jude Medical LLC Company Overview 30

5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Suzhou SyMap Medical Ltd Company Overview 31

5.8.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Verve Medical, Inc. Company Overview 34

5.9.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

6 Radiofrequency Catheters- Recent Developments 35

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 35

6.2 May 23, 2018: New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication 37

6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 38

6.4 May 09, 2018: Upmc Pinnacle Participating In Groundbreaking Trial To Help Lower Blood Pressure 39

6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 39

6.6 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 40

6.7 Apr 09, 2018: Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension 40

6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 41

6.9 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 42

6.10 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 42

6.11 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 43

6.12 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership 45

6.13 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 46

6.14 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 47

6.15 Nov 24, 2017: MicroPort EP's Contact Force Sensing RF Ablation Catheter Gains CFDA Green-Path 47

6.16 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 47

6.17 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 50

6.18 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 51

6.19 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52

6.20 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 53

6.21 Aug 28, 2017: Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions 54

6.22 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 56

7 Appendix 59

7.1 Methodology 59

7.2 About GlobalData 62

7.3 Contact Us 62

7.4 Disclaimer 62


List Of Figure

1.2 List of Figures

Figure 1: Radiofrequency Catheters-Pipeline Products by Stage of Development 7

Figure 2: Radiofrequency Catheters-Pipeline Products by Territory 8

Figure 3: Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

Figure 4: Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

Figure 5: Radiofrequency Catheters-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Radiofrequency Catheters-Pipeline Products by Stage of Development 7

Table 2: Radiofrequency Catheters-Pipeline Products by Territory 8

Table 3: Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

Table 4: Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

Table 5: Radiofrequency Catheters-Ongoing Clinical Trials 11

Table 6: Radiofrequency Catheters Companies-Pipeline Products by Stage of Development 12

Table 7: Radiofrequency Catheters-Pipeline Products by Stage of Development 13

Table 8: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: 2nd Gen Renal Denervation System-Product Status 14

Table 10: 2nd Gen Renal Denervation System-Product Description 15

Table 11: 3rd Gen Renal Denervation System-Product Status 15

Table 12: 3rd Gen Renal Denervation System-Product Description 15

Table 13: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16

Table 14: DENEX-Product Status 16

Table 15: DENEX-Product Description 16

Table 16: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

Table 17: Renal Denervation Catheter-Product Status 17

Table 18: Renal Denervation Catheter-Product Description 17

Table 19: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: Symplicity Renal Denervation System-Product Status 18

Table 21: Symplicity Renal Denervation System-Product Description 19

Table 22: Symplicity Spyral Renal Denervation Catheter-Product Status 19

Table 23: Symplicity Spyral Renal Denervation Catheter-Product Description 19

Table 24: Medtronic plc-Ongoing Clinical Trials Overview 20

Table 25: Symplicity Renal Denervation System-A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF) 21

Table 26: Symplicity Renal Denervation System-Effects of Catheter Based Renal Sympathetic Denervation on Resistant Hypertension in End Stage Renal Disease in Korea 21

Table 27: Symplicity Renal Denervation System-Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry 21

Table 28: Symplicity Renal Denervation System-Impact of Renal Artery Denervation in Patients with Chronic Heart Failure Compared with Sham Procedure 22

Table 29: Symplicity Renal Denervation System-Prairie Renal Denervation Study 22

Table 30: Symplicity Renal Denervation System-Renal Denervation in Treatment Resistant Hypertension 22

Table 31: Symplicity Renal Denervation System-Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study 23

Table 32: Symplicity Renal Denervation System-Understanding the Mechanisms of Progressive Decrease In Blood Pressure After Renal Nerve Ablation 23

Table 33: Symplicity Spyral Renal Denervation Catheter-A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries 24

Table 34: Symplicity Spyral Renal Denervation Catheter-Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes 24

Table 35: Symplicity Spyral Renal Denervation Catheter-Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications: SPYRAL HTN-OFF MED 24

Table 36: Symplicity Spyral Renal Denervation Catheter-Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED 25

Table 37: Symplicity Spyral Renal Denervation Catheter-Pivotal Study for the Assessment of Safety and Efficacy of Symplicity Spyral Renal Denervation System in Subjects with Hypertension 25

Table 38: Symplicity Spyral Renal Denervation Catheter-Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation 25

Table 39: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 40: FlashPoint Renal Artery RF Ablation Catheter-Product Status 26

Table 41: FlashPoint Renal Artery RF Ablation Catheter-Product Description 26

Table 42: Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Table 43: ReDy Renal Denervation System-Product Status 27

Table 44: ReDy Renal Denervation System-Product Description 27

Table 45: Renal Dynamics, LLC-Ongoing Clinical Trials Overview 28

Table 46: ReDy Renal Denervation System-A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy Renal Denervation System in the Treatment of Patients with Uncontrolled Hypertension 29

Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Table 48: Third Generation EnligHTN Renal Denervation System-Product Status 30

Table 49: Third Generation EnligHTN Renal Denervation System-Product Description 30

Table 50: Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 51: SyMapCath I Catheter-Product Status 31

Table 52: SyMapCath I Catheter-Product Description 31

Table 53: Suzhou SyMap Medical Ltd-Ongoing Clinical Trials Overview 32

Table 54: SyMapCath I Catheter-A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial) 33

Table 55: Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 56: Verve Medical System-Product Status 34

Table 57: Verve Medical System-Product Description 34

Table 58: Glossary 61

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Handok Inc, 2nd Gen Renal Denervation System; Handok Inc, 3rd Gen Renal Denervation System; Handok-Kalos Medical, DENEX; Lifetech Scientific (Shenzhen) Co Ltd, Renal Denervation Catheter; Medtronic plc, Symplicity Renal Denervation System; Medtronic plc, Symplicity Spyral Renal Denervation Catheter; MicroPort Scientific Corp, FlashPoint Renal Artery RF Ablation Catheter; Renal Dynamics, LLC, ReDy Renal Denervation System; St. Jude Medical LLC, Third Generation EnligHTN Renal Denervation System; Suzhou SyMap Medical Ltd, SyMapCath I Catheter; Verve Medical, Inc., Verve Medical System


Companies

Handok Inc

Handok-Kalos Medical

Lifetech Scientific (Shenzhen) Co Ltd

Medtronic plc

MicroPort Scientific Corp

Renal Dynamics, LLC

St. Jude Medical LLC

Suzhou SyMap Medical Ltd

Verve Medical, Inc.

Radiofrequency Catheters-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Radiofrequency Catheters-Medical Devices Pipeline Assessment, 2018 provides an overview of Radiofrequency Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Radiofrequency Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Radiofrequency Catheters under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Radiofrequency Catheters and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Radiofrequency Catheters under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Radiofrequency Catheters Overview 6

3 Products under Development 7

3.1 Radiofrequency Catheters-Pipeline Products by Stage of Development 7

3.2 Radiofrequency Catheters-Pipeline Products by Territory 8

3.3 Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

3.4 Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

3.5 Radiofrequency Catheters-Ongoing Clinical Trials 11

4 Radiofrequency Catheters-Pipeline Products under Development by Companies 12

4.1 Radiofrequency Catheters Companies-Pipeline Products by Stage of Development 12

4.2 Radiofrequency Catheters-Pipeline Products by Stage of Development 13

5 Radiofrequency Catheters Companies and Product Overview 14

5.1 Handok Inc Company Overview 14

5.1.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Handok-Kalos Medical Company Overview 16

5.2.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 17

5.3.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Medtronic plc Company Overview 18

5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 MicroPort Scientific Corp Company Overview 26

5.5.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Renal Dynamics, LLC Company Overview 27

5.6.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 St. Jude Medical LLC Company Overview 30

5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Suzhou SyMap Medical Ltd Company Overview 31

5.8.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Verve Medical, Inc. Company Overview 34

5.9.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

6 Radiofrequency Catheters- Recent Developments 35

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 35

6.2 May 23, 2018: New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication 37

6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 38

6.4 May 09, 2018: Upmc Pinnacle Participating In Groundbreaking Trial To Help Lower Blood Pressure 39

6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 39

6.6 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 40

6.7 Apr 09, 2018: Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension 40

6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 41

6.9 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 42

6.10 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 42

6.11 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 43

6.12 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership 45

6.13 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 46

6.14 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 47

6.15 Nov 24, 2017: MicroPort EP's Contact Force Sensing RF Ablation Catheter Gains CFDA Green-Path 47

6.16 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 47

6.17 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 50

6.18 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 51

6.19 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52

6.20 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 53

6.21 Aug 28, 2017: Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions 54

6.22 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 56

7 Appendix 59

7.1 Methodology 59

7.2 About GlobalData 62

7.3 Contact Us 62

7.4 Disclaimer 62


List Of Figure

1.2 List of Figures

Figure 1: Radiofrequency Catheters-Pipeline Products by Stage of Development 7

Figure 2: Radiofrequency Catheters-Pipeline Products by Territory 8

Figure 3: Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

Figure 4: Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

Figure 5: Radiofrequency Catheters-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Radiofrequency Catheters-Pipeline Products by Stage of Development 7

Table 2: Radiofrequency Catheters-Pipeline Products by Territory 8

Table 3: Radiofrequency Catheters-Pipeline Products by Regulatory Path 9

Table 4: Radiofrequency Catheters-Pipeline Products by Estimated Approval Date 10

Table 5: Radiofrequency Catheters-Ongoing Clinical Trials 11

Table 6: Radiofrequency Catheters Companies-Pipeline Products by Stage of Development 12

Table 7: Radiofrequency Catheters-Pipeline Products by Stage of Development 13

Table 8: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: 2nd Gen Renal Denervation System-Product Status 14

Table 10: 2nd Gen Renal Denervation System-Product Description 15

Table 11: 3rd Gen Renal Denervation System-Product Status 15

Table 12: 3rd Gen Renal Denervation System-Product Description 15

Table 13: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16

Table 14: DENEX-Product Status 16

Table 15: DENEX-Product Description 16

Table 16: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

Table 17: Renal Denervation Catheter-Product Status 17

Table 18: Renal Denervation Catheter-Product Description 17

Table 19: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: Symplicity Renal Denervation System-Product Status 18

Table 21: Symplicity Renal Denervation System-Product Description 19

Table 22: Symplicity Spyral Renal Denervation Catheter-Product Status 19

Table 23: Symplicity Spyral Renal Denervation Catheter-Product Description 19

Table 24: Medtronic plc-Ongoing Clinical Trials Overview 20

Table 25: Symplicity Renal Denervation System-A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF) 21

Table 26: Symplicity Renal Denervation System-Effects of Catheter Based Renal Sympathetic Denervation on Resistant Hypertension in End Stage Renal Disease in Korea 21

Table 27: Symplicity Renal Denervation System-Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry 21

Table 28: Symplicity Renal Denervation System-Impact of Renal Artery Denervation in Patients with Chronic Heart Failure Compared with Sham Procedure 22

Table 29: Symplicity Renal Denervation System-Prairie Renal Denervation Study 22

Table 30: Symplicity Renal Denervation System-Renal Denervation in Treatment Resistant Hypertension 22

Table 31: Symplicity Renal Denervation System-Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study 23

Table 32: Symplicity Renal Denervation System-Understanding the Mechanisms of Progressive Decrease In Blood Pressure After Renal Nerve Ablation 23

Table 33: Symplicity Spyral Renal Denervation Catheter-A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries 24

Table 34: Symplicity Spyral Renal Denervation Catheter-Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes 24

Table 35: Symplicity Spyral Renal Denervation Catheter-Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications: SPYRAL HTN-OFF MED 24

Table 36: Symplicity Spyral Renal Denervation Catheter-Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED 25

Table 37: Symplicity Spyral Renal Denervation Catheter-Pivotal Study for the Assessment of Safety and Efficacy of Symplicity Spyral Renal Denervation System in Subjects with Hypertension 25

Table 38: Symplicity Spyral Renal Denervation Catheter-Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation 25

Table 39: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 40: FlashPoint Renal Artery RF Ablation Catheter-Product Status 26

Table 41: FlashPoint Renal Artery RF Ablation Catheter-Product Description 26

Table 42: Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Table 43: ReDy Renal Denervation System-Product Status 27

Table 44: ReDy Renal Denervation System-Product Description 27

Table 45: Renal Dynamics, LLC-Ongoing Clinical Trials Overview 28

Table 46: ReDy Renal Denervation System-A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy Renal Denervation System in the Treatment of Patients with Uncontrolled Hypertension 29

Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Table 48: Third Generation EnligHTN Renal Denervation System-Product Status 30

Table 49: Third Generation EnligHTN Renal Denervation System-Product Description 30

Table 50: Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 51: SyMapCath I Catheter-Product Status 31

Table 52: SyMapCath I Catheter-Product Description 31

Table 53: Suzhou SyMap Medical Ltd-Ongoing Clinical Trials Overview 32

Table 54: SyMapCath I Catheter-A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial) 33

Table 55: Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 56: Verve Medical System-Product Status 34

Table 57: Verve Medical System-Product Description 34

Table 58: Glossary 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Handok Inc, 2nd Gen Renal Denervation System; Handok Inc, 3rd Gen Renal Denervation System; Handok-Kalos Medical, DENEX; Lifetech Scientific (Shenzhen) Co Ltd, Renal Denervation Catheter; Medtronic plc, Symplicity Renal Denervation System; Medtronic plc, Symplicity Spyral Renal Denervation Catheter; MicroPort Scientific Corp, FlashPoint Renal Artery RF Ablation Catheter; Renal Dynamics, LLC, ReDy Renal Denervation System; St. Jude Medical LLC, Third Generation EnligHTN Renal Denervation System; Suzhou SyMap Medical Ltd, SyMapCath I Catheter; Verve Medical, Inc., Verve Medical System


Companies

Handok Inc

Handok-Kalos Medical

Lifetech Scientific (Shenzhen) Co Ltd

Medtronic plc

MicroPort Scientific Corp

Renal Dynamics, LLC

St. Jude Medical LLC

Suzhou SyMap Medical Ltd

Verve Medical, Inc.